Citations

Mayo Clinic

Clear

6724 citation(s) found for "Wu, Mark".

Genetic Variation in the One-Carbon Transfer Pathway and Ovarian Cancer Risk
Kelemen, Linda E. , Sellers, Thomas A. , Schildkraut, Joellen M. , Cunningham, Julie M. , Vierkant, Robert A. , Pankratz, V. Shane , Fredericksen, Zachary S., Gadre, Madhura K., Rider, David N., Liebow, Mark , Goode, Ellen L. , Vierkant, Robert A

Cancer Research | April 1, 2008 | Volume: 68 | Issue: 7 | Pages: 2498-2506

10.1158/0008-5472.can-07-5165 | PMID 18381459 Get It

Abstract Dysfunction in enzymes involved in one-carbon (1-C) metabolism can lead to increased chromosomal strand breaking and abnormal methylation patterns, which are both associated with cancer risk. Availability of 1-C units may modify risk. We investigated the association of single-nucleotide polymorphisms (SNP) in 21 genes in the 1-C transfer pathway among 829 Caucasian cases with primary epithelial ovarian cancer and 941 frequency-matched unaffected controls enrolled at Mayo Clinic (Rochester, MN) and Duke University (Durham, NC) and examined risk modification by multivitamin supplement use. Multivariable-adjusted SNP-specific logistic regression and haplotype analyses were done for 180 SNPs and false positive report probabilities (FPRP) were calculated. Each copy of the minor allele in SHMT1 intron 5 A>G (rs9909104) was associated with epithelial ovarian cancer [odds ratio (OR), 1.2; 95% confidence interval (95% CI), 1.0–1.4; P trend = 0.02; FPRP = 0.16] and a 5-SNP SHMT1 haplotype was associated with decreased risk (P = 0.01; FPRP = 0.09). Three SNPs in DNMT3A were associated with risk among multivitamin supplement users: 3′ untranslated region (UTR) C>G (rs13420827: OR, 0.8; 95% CI, 0.6–1.0; P interaction = 0.006; FPRP = 0.54), intron 6 G>A (rs11887120: OR, 0.8; 95% CI, 0.7–1.0; P interaction = 0.007; FPRP = 0.57), and intron 22 A>T (rs11695471: OR, 1.2; 95% CI, 1.0–1.5; P interaction = 0.01; FPRP = 0.66). These data extend previous findings from other cancers of a role for SHMT1 in ovarian cancer, and provide evidence that SNPs in methylation and DNA synthesis reactions are associated with risk of ovarian cancer. Interventions with modifiable factors such as multivitamin intake may reduce risk. [Cancer Res 2008;68(7):2498–506]
Postoperative Evaluation of the Total Ankle Arthroplasty
Peterson, Jeffrey J., DeOrio, James K. , Bancroft, Laura W. , Berquist, Thomas H., Kransdorf, Mark J. , Bestic, Joseph M.

American Journal of Roentgenology | March 20, 2008 | Volume: 190 | Issue: 4 | Pages: 1112-1123

10.2214/ajr.07.2729 | PMID 18356463 Get It

Src-mediated Cortactin Phosphorylation Regulates Actin Localization and Injurious Blebbing in Acinar Cells
Singh, Vijay , McNiven, Mark A. , Singh, Vijay P

Molecular Biology of the Cell | March 20, 2008 | Volume: 19 | Issue: 5 | Pages: 2339-2347

10.1091/mbc.e07-11-1130 | PMID 18353971 Get It

Suprastimulation of pancreatic acini is a well-known model for pancreatitis, and it is characterized by actin reorganization and cell blebbing. Currently, however, the mechanisms underlying regulation of these aberrant cytoskeletal and membrane dynamics and how they contribute to cell injury are unclear. We observed that suprastimulation results in a rapid activation of Src and relocalization of the actin-binding protein cortactin from the apical to the basolateral domain at the necks of membrane blebs. Furthermore, Src-mediated cortactin tyrosine phosphorylation was markedly increased after suprastimulation. Pretreatment of acini with Src inhibitors or expression of a cortactin tyrosine phospho-inhibitory mutant reduced actin redistribution and bleb formation induced by suprastimulation in vitro. Importantly, inhibition of Src activity in rat models of suprastimulation-induced pancreatitis substantially reduced disease severity, as indicated by a reduction in serum amylase and pancreatic edema and a striking improvement in tissue histology. These findings indicate a novel, disease-relevant role for Src-mediated cortactin phosphorylation in aberrant reorganization of the actin cytoskeleton, a mechanism that is likely to have implications in other types of cell injury. In addition, they suggest a potential use for Src inhibitors as an approach to reduce cell injury.
Whole Genome Analyses Suggest Ischemic Stroke and Heart Disease Share an Association With Polymorphisms on Chromosome 9p21
Matarín, Mar, Brown, W. Mark , Singleton, Andrew , Hardy, John , Meschia, James F. , Hardy, John

Stroke | March 15, 2008 | Volume: 39 | Issue: 5 | Pages: 1586-1589

10.1161/strokeaha.107.502963 | PMID 18340101 Get It

Background and Purpose— Recently independent studies reported an association between coronary heart disease and single-nucleotide polymorphisms (SNPs) located at chromosome 9p21, near CDKN2A and CDKN2B genes. Given that stroke is a common complication after myocardial infarction, we investigated if the same SNPs were associated with ischemic stroke in our population. Methods— We recently initiated a whole genome analysis of ischemic stroke and published the first stage of a case control study using >400 000 SNPs from Illumina Infinium Human-1 and HumanHap300 assays. We focused on SNPs recently associated with heart disease by Helgadottir and colleagues and SNPs from the same haplotype block. Results— In analyses both unadjusted and adjusted for stroke risk factors, significant associations with ischemic stroke were observed for SNPs from the same haplotype block previously associated with myocardial infarction. Significant association was also seen between disease and haplotypes involving these SNPs, both with and without adjustment for stroke risk factors (odd ratios: 1.01 to 2.65). Conclusions— These data are important for 3 reasons: first, they suggest a genetic association for stroke; second, they suggest that this association shares pathogenic mechanisms with heart disease and diabetes; and third, they illustrate, that public release of data can facilitate rapid risk locus discovery.
A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension
Oparil, Suzanne , Abate, Nicola , Chen, E., Galet, Vincent A., Jia, Gang , Julius, Stevo, Lerman, A., Lyle, Paulette A., Pool, James L., Tershakovec, Andrew M. , Creager, Mark A.

Current Medical Research and Opinion | March 8, 2008 | Volume: 24 | Issue: 4 | Pages: 1101-1114

10.1185/030079908x280716 | PMID 18328120 Get It

Cognitive Bias, Functional Cortical Geometry, and the Frontal Lobes: Laterality, Sex, and Handedness
Goldberg, Elkhonon , Harner, Richard N., Podell, Kenneth , Riggio, Silvma, Lovell, Mark R. , Riggio, S

Journal of Cognitive Neuroscience | February 29, 2008 | Volume: 6 | Issue: 3 | Pages: 276-296

10.1162/jocn.1994.6.3.276 | PMID 23964977 Get It

AbstractPerformance of patients with quadrant lesions on the inherently ambiguous Cognitive Bias Task (CBT) suggests sexual dimorphism in the fundamental aspects of functional cortical geometry, by emphasizing different cerebral axes. In right-handed males, extreme context-dependent and context-independent response selection biases are reciprocally linked to left vs. right frontal systems. In right-handed females, these complementary biases appear to be reciprocally linked to posterior vs. frontal cortices. Frontal lobe functions are more lateralized in males than females due to sexual dimorphism of the left frontal systems. Both in males and females, patterns of CBT scores in non-right-handers with quadrant lesions are opposite to those found in right-handers. This suggests the existence of two functionally and neurally distinct cognitive selection mechanisms. Both mechanisms involve the frontal lobes, but their exact neuroanatomy depends on sex and handedness.
An Anomalous Haplotype Distribution of the Arrestin Domain–Containing 4 Gene ( ARRDC4 ) Haplotypes in Caucasians
Knoll, Bettina M. , Goldammer, Mark, Wojewoda, Agnieszka, Flügge, Jana, Johne, Andreas , Mrozikiewicz, P.M., Roots, Ivar, Köpke, Karla

Genetic Testing | February 28, 2008 | Volume: 12 | Issue: 1 | Pages: 147-152

10.1089/gte.2007.0049 | PMID 18307387 Get It

Imaging Appearance of Diffuse Neurofibroma
Hassell, D., Bancroft, Laura W. , Kransdorf, Mark J. , Peterson, Jeffrey J., Berquist, Thomas H., Murphey, Mark D. , Fanburg–Smith, Julie C.

American Journal of Roentgenology | February 21, 2008 | Volume: 190 | Issue: 3 | Pages: 582-588

10.2214/ajr.07.2589 | PMID 18287425 Get It

Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS
Parisi, Joseph E. , Lucchinetti, Claudia F. , Boeve, B. F., Josephs, K., Keegan, B. Mark , Giannini, Caterina

Neurology | February 20, 2008 | Volume: 70 | Issue: 13_part_2 | Pages: 1128-1133

10.1212/01.wnl.0000304045.99153.8f | PMID 18287567 Get It

Combined Newborn Screening for Succinylacetone, Amino Acids, and Acylcarnitines in Dried Blood Spots
Turgeon, Coleman , Magera, Mark J , Tortorelli, Silvia , Gavrilov, Dimitar , Oglesbee, Devin , Raymond, Kimiyo , Rinaldo, Piero, Matern, Dietrich , Allard, Pierre , Oglesbee, Devin

Clinical Chemistry | February 15, 2008 | Volume: 54 | Issue: 4 | Pages: 657-664

10.1373/clinchem.2007.101949 | PMID 18281422 Get It

Abstract Background: Tyrosinemia type I (TYR 1) is a disorder causing early death if left untreated. Newborn screening (NBS) for this condition is problematic because determination of the diagnostic marker, succinylacetone (SUAC), requires a separate first-tier or only partially effective second-tier analysis based on tyrosine concentration. To overcome these problems, we developed a new assay that simultaneously determines acylcarnitines (AC), amino acids (AA), and SUAC in dried blood spots (DBS) by flow injection tandem mass spectrometry (MS/MS). Methods: We extracted 3/16-inch DBS punches with 300 μL methanol containing AA and AC stable isotope-labeled internal standards. This extract was derivatized with butanol-HCl. In parallel, we extracted SUAC from the residual filter paper with 100 μL of a 15 mmol/L hydrazine solution containing the internal standard 13C5-SUAC. We combined the derivatized aliquots in acetonitrile for MS/MS analysis of AC and AA with additional SRM experiments for SUAC (m/z 155–137) and 13C5-SUAC (m/z 160–142). Analysis time was 1.2 min. Results: SUAC was increased in retrospectively analyzed NBS samples of 11 TYR 1 patients (length of storage, 52 months to 1 week; SUAC range, 13–81 μmol/L), with Tyr concentrations ranging from 65 to 293 μmol/L in the original NBS analysis. The mean concentration of SUAC in 13 521 control DBS was 1.25 μmol/L. Conclusion: The inclusion of SUAC analysis into routine analysis of AC and AA allows for rapid and cost-effective screening for TYR 1 with no tangible risk of false-negative results.